XML 29 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital & Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (shares) at Dec. 31, 2017   20,135,514    
Beginning balance at Dec. 31, 2017 $ 290,529 $ 2 $ 98,731 $ 191,796
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 345     345
Purchase of common stock for tax withholding (shares)   (56,269)    
Purchase of common stock for tax withholding (892)   (892)  
Amortization of stock-based compensation 1,234   1,234  
Cash dividends declared (2,589)     (2,589)
Common stock repurchase program including commissions (shares)   (127,792)    
Common stock repurchase program including commissions (1,927)   (1,927)  
Issuance of restricted stock under the Equity Plan and other (shares)   4,812    
Cumulative translation adjustment (256)   (256)  
Ending balance (shares) at Mar. 31, 2018   19,956,265    
Ending balance at Mar. 31, 2018 291,088 $ 2 96,890 194,196
Beginning balance (shares) at Dec. 31, 2017   20,135,514    
Beginning balance at Dec. 31, 2017 290,529 $ 2 98,731 191,796
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (1,667)      
Ending balance (shares) at Sep. 30, 2018   19,449,318    
Ending balance at Sep. 30, 2018 278,388 $ 2 90,829 187,557
Beginning balance (shares) at Mar. 31, 2018   19,956,265    
Beginning balance at Mar. 31, 2018 291,088 $ 2 96,890 194,196
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (1,172)     (1,172)
Amortization of stock-based compensation 1,267   1,267  
Cash dividends declared (2,539)     (2,539)
Common stock repurchase program including commissions (shares)   (501,782)    
Common stock repurchase program including commissions (7,540)   (7,540)  
Issuance of restricted stock under the Equity Plan and other (shares)   17,766    
Issuance of restricted stock under the Equity Plan and other 143   143  
Cumulative translation adjustment (342)   (342)  
Ending balance (shares) at Jun. 30, 2018   19,472,249    
Ending balance at Jun. 30, 2018 280,905 $ 2 90,418 190,485
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (840)     (840)
Purchase of common stock for tax withholding (86)   (86)  
Amortization of stock-based compensation 1,423   1,423  
Cash dividends declared (2,500)     (2,500)
Common stock repurchase program including commissions (shares)   (36,542)    
Common stock repurchase program including commissions (559)   (559)  
Issuance of restricted stock under the Equity Plan and other (shares)   13,611    
Cumulative translation adjustment (367)   (367)  
Prior period adjustments 412     412
Ending balance (shares) at Sep. 30, 2018   19,449,318    
Ending balance at Sep. 30, 2018 278,388 $ 2 90,829 187,557
Beginning balance (shares) at Dec. 31, 2018   19,389,066    
Beginning balance at Dec. 31, 2018 274,554 $ 2 89,258 185,294
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 742     742
Purchase of common stock for tax withholding (shares)   (67,648)    
Purchase of common stock for tax withholding (1,011)   (1,011)  
Amortization of stock-based compensation 528   528  
Cash dividends declared (2,479)     (2,479)
Common stock repurchase program including commissions (shares)   (131,012)    
Common stock repurchase program including commissions (1,810)   (1,810)  
Issuance of restricted stock under the Equity Plan and other (shares)   13,650    
Issuance of restricted stock under the Equity Plan and other 70     70
Cumulative translation adjustment (60)   (60)  
Ending balance (shares) at Mar. 31, 2019   19,204,056    
Ending balance at Mar. 31, 2019 270,534 $ 2 86,905 183,627
Beginning balance (shares) at Dec. 31, 2018   19,389,066    
Beginning balance at Dec. 31, 2018 274,554 $ 2 89,258 185,294
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (1,255)      
Ending balance (shares) at Sep. 30, 2019   18,827,770    
Ending balance at Sep. 30, 2019 260,797 $ 2 84,115 176,680
Beginning balance (shares) at Mar. 31, 2019   19,204,056    
Beginning balance at Mar. 31, 2019 270,534 $ 2 86,905 183,627
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (670)     (670)
Amortization of stock-based compensation 1,029   1,029  
Cash dividends declared (2,480)     (2,480)
Issuance of restricted stock under the Equity Plan and other (shares)   17,910    
Issuance of restricted stock under the Equity Plan and other 120   120  
Cumulative translation adjustment (33)   (33)  
Ending balance (shares) at Jun. 30, 2019   19,221,966    
Ending balance at Jun. 30, 2019 268,500 $ 2 88,021 180,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (1,326)     (1,326)
Amortization of stock-based compensation 964   964  
Cash dividends declared (2,471)     (2,471)
Common stock repurchase program including commissions (shares)   (401,342)    
Common stock repurchase program including commissions (4,765)   (4,765)  
Issuance of restricted stock under the Equity Plan and other (shares)   7,146    
Cumulative translation adjustment (105)   (105)  
Ending balance (shares) at Sep. 30, 2019   18,827,770    
Ending balance at Sep. 30, 2019 $ 260,797 $ 2 $ 84,115 $ 176,680